Bristol Myers acquires cell therapy partner 2seventy bio
In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other Friday’s ...
Bristol-Myers Squibb has won FDA approval for the first ... ballpark as the Opdivo/Yervoy combination for melanoma. BMS sues AZ, claiming Imfinzi infringes Opdivo patents BMS, meanwhile, has ...
The stock's fall snapped a four-day winning streak.
In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other best dividend stocks to buy according to billionaires. Dividend stocks have been ...
Bristol-Myers Squibb (NYSE:BMY – Get Free Report)’s stock price hit a new 52-week high during trading on Friday .The stock traded as high as $61.68 and last traded at $61.90, with a volume of ...
Bristol Myers Squibb stock (NYSE: BMY) has gained 7% this year, outperforming the S&P 500 which has declined 1%. BMS’s strong Q4 performance has helped drive its positive momentum. While markets ...
In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other best drug stocks to buy now. Large American pharmaceutical companies are showing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback